Literature DB >> 27500084

Neonatal encephalitis due to Chikungunya vertical transmission: First report in Brazil.

Antonio Carlos Bandeira1, Gubio Soares Campos2, Silvia Ines Sardi2, Veronica França Diniz Rocha3, Guilherme Cesar Mendes Rocha4.   

Abstract

PURPOSE: To report the first case of Chikungunya encephalitis acquired in the perinatal period during the current outbreak in Brazil.
METHODS: Case report.
RESULTS: A male neonate with 3500 g developed macular erythematous rash, hypoactivity and fever progressing to generalized seizures. His mother had experienced a disseminated rash and fever before delivery. EEG showed diffuse slowing and cranial NMR was suggestive of encephalitis. Rt-PCR for Chikungunya virus (CHIKV) was positive in cerebrospinal fluid (CSF), blood, urine and saliva. The newborn was discharged home with neurological improvement.
CONCLUSION: We report the first case of a perinatal CHIKV infection associated with a rapidly evolving encephalitis and an extensive dissemination of the virus as documented by positive rt-PCR results in CSF, blood, urine and saliva in the present outbreak in Brazil. In countries experiencing outbreaks of CHIKV infections, clinicians and neonatologists must be familiar with the possibility of the occurrence of neurologic complications and its possible consequences.

Entities:  

Keywords:  Chikungunya neonatal; Chikungunya-associated encephalitis; Neonatal encephalitis; Neurological syndromes; Vertical transmission.

Year:  2016        PMID: 27500084      PMCID: PMC4971151          DOI: 10.1016/j.idcr.2016.07.008

Source DB:  PubMed          Journal:  IDCases        ISSN: 2214-2509


Why this case is important

CHIKV is a RNA virus belonging to the Alphavirus Family and transmitted by Aedes mosquitoes. The disease is usually manifested as fever, arthralgia and rash. In 2014 the first autochthonous cases of CHIKV in Brazil were confirmed and, since then, the disease has spread throughout the country [1]. Neurological complications are rare but have been increasingly reported in newborns and adults. Neurocognitive outcomes in neonates exposed to perinatal CHIKV infections have revealed neurodevelopmental delays, cerebral palsies and microcephaly [2]. And vertical transmission has been implicated in nine cases of CHIKV encephalopathy in the La Reunion Island in 2005–2006 [3]. This case reveals the potential of a serious neurological involvement in a newborn with acute CHIKV acquired in the perinatal period and represents the first description of neonatal CHIKV-encephalitis in Brazil since the start of the outbreak.

Case description

LCVA, 35 yr-old, gave birth in November 24th, 2015 of a male neonate with 3500 g, cephalic perimeter of 34.0 cm and with normal vital signs at Hospital Aliança, a 210 bed tertiary hospital in Salvador, Brazil. Antenatal visits were normal except for reporting that four days before a C-section delivery she experienced a disseminated rash and fever with dengue serology positive for IgG and negative for IgM. The neonate was doing well until November 28th when the newborn developed a macular erythematous rash, hypoactivity and temperature of 37.9 °C. On November 30th, the neonate began presenting generalized seizures that responded to anticonvulsants. Blood, saliva, urine, and CSF samples were screened for CHIKV, Zika, and Dengue using rt-PCR techniques [4], [5]. Briefly, RNA was extracted using QIAmp Viral RNA mini kit according to manufactureŕs instructions for CHIKV. The amplification product was 305 bp within the gene that codes for the viral envelope protein E2 of CHIKV [4]. For Zika virus, the amplicon product was 192 bp within the gene that codes for the viral NS5 region [5]. HSV was screened in CSF and Acyclovir was initiated. EEG showed diffuse slowing compatible with the diagnosis of encephalitis. Brain NMR showed hyperintensity signals on diffusion-weighted imaging (DWI) involving the subcortical white matter of the frontal, parietal, temporal areas, and the corpus callosum as shown in Figs. 1–3 , and were unremarkable in T1 or T2 weighted images with no enhancement in post-contrast T1-weighted NMR imaging (Fig. 4).
Fig. 4

Post-contrast T1-weighted.

NMR imaging of the brain showing no enhancement of the lesions. CSF results: 0.7 mononuclear cells per mm3, protein 106 mg/dL; glucose 23 mg/dl; immune markers for syphilis (Fta-Abs, VDRL) and toxoplasmosis (indirect immunofluorescence assay) were negative; and aerobic, mycobacterial and fungal cultures were all negative. Rt-PCR for CHIKV was positive in CSF, blood, urine and saliva. Rt-PCR for Zika virus, Dengue virus, and HSV were all negative. The newborn began to show improvement in neurological parameters, being more active, from December 9th and was discharged home on December 16th. The newborn was more active, less hypotonic, and showing a normal sucking and palmar grasp reflexes.

Other similar and contrasting cases in the literature

Géraldin et cols presented cases of CHIKV encephalopathy with a similar pattern of neurological involvement as seen in our case and indicative of an early cytotoxic edema with marked reduction of the apparent diffusion coefficient [3]. In La Reunión Island CHIKV outbreak during 2005–2006, cases of chikungunya-associated encephalitis contributed to a two-fold increase in the regional overall incidence of all encephalitis [6]. During an outbreak in India 3 fatal cases in children were documented and were associated with nervous system complications [7], [8]. In the La Reunión epidemic, a similar report of 3 deaths were documented in children under 18 years, and 2 of them were due to encephalitis [9]. The pathogenic mechanism of the various neurological syndromes during CHIKV infection is largely unknown. Neurological involvement in CHIKV infection may include encephalitis [10], meningoencephalitis [11], encephalomyeloradiculitis [12], among others. Casolari et cols have described a 83 year-old patient from Italy with a fatal encephalitis in the course of a CHIKV infection and suggested a possible association between high viral load that was found in CSF and serum and the poor outcome [13]. We did not quantify CHIKV viral load in this case even though we did find positive molecular results in many different body fluids possibly indicating a high replicative viral kinetics. In our case report, the woman was submitted to a C-section but a possible benefit of this intervention to prevent vertical transmission of CHIKV was not confirmed in another study of 10 vertical CHIKV transmission cases [14]. Pierre-Yves Robillard et cols have described 10 cases of vertical transmission of CHIKV virus to neonates and the onset of symptoms occurred between three to seven days after birth [14]. Neonates born to viraemic women diagnosed during labor or during the last 4 weeks before delivery may have serious outcomes [15], as was also observed in a case series from Colombia [16]. CHIKV lesions generally present as a multifocal brain involvement, affecting structures such as temporal lobes, insular cortices, basal ganglia and periventricular white matter [11], [12]. The brain lesions presented in our case had a distribution similar to the ones described in the literature and associated with CHIKV encephalitis. The restricted diffusion abnormalities seen in NMR imaging usually precedes signal abnormalities seen on fluid-attenuated inversion recovery (FLAIR) images and is also known to resolve earlier than the FLAIR signal abnormalities during the recovery period [11], [12].

Discussion

This case report of a vertical CHIKV-associated encephalitis documented with rt-PCR in the CSF, blood, urine and saliva represents the first description of this neurological involvement in a neonate since the introduction of CHIKV in Brazil in 2014. It has been a huge challenge the rapid differential diagnosis of serious neurological complications in a scenario of concurrent arboviral diseases in Brazil since we have been faced with the Zika outbreak and the reappearance of DENV-4 [17], [18]. In countries experiencing outbreaks of CHIKV infections, clinicians and neonatologists must be familiar with the possibility of this serious neurological involvement and its possible consequences.

Conflict of interests

The authors declare no competing interests.

Funding

None.

Ethical approval

Approved.
  15 in total

Review 1.  [Chikungunya virus infection: review through an epidemic].

Authors:  G Pialoux; B-A Gaüzère; M Strobel
Journal:  Med Mal Infect       Date:  2006-05-24       Impact factor: 2.152

2.  Post chikungunya brain stem encephalitis.

Authors:  L A Gauri; B L Ranwa; K Nagar; A Vyas; Q Fatima
Journal:  J Assoc Physicians India       Date:  2012-04

3.  A diagnostic polymerase chain reaction assay for Zika virus.

Authors:  Michelle N D Balm; Chun Kiat Lee; Hong Kai Lee; Lily Chiu; Evelyn S C Koay; Julian W Tang
Journal:  J Med Virol       Date:  2012-09       Impact factor: 2.327

4.  [Vertical maternal fetal transmission of the chikungunya virus. Ten cases among 84 pregnant women].

Authors:  Pierre-Yves Robillard; Brahim Boumahni; Patrick Gérardin; Alain Michault; Alain Fourmaintraux; Isabelle Schuffenecker; Magali Carbonnier; Sam Djémili; Ghassan Choker; Madeleine Roge-Wolter; Georges Barau
Journal:  Presse Med       Date:  2006-05       Impact factor: 1.228

5.  A fatal case of encephalitis associated with Chikungunya virus infection.

Authors:  Stefania Casolari; Elisabetta Briganti; Miriam Zanotti; Tiziano Zauli; Loredana Nicoletti; Fabio Magurano; Claudia Fortuna; Cristiano Fiorentini; Maria Grazia Ciufolini; Giovanni Rezza
Journal:  Scand J Infect Dis       Date:  2008

6.  Chikungunya encephalomyeloradiculitis: report of 2 cases with neuroimaging and 1 case with autopsy findings.

Authors:  K Ganesan; A Diwan; S K Shankar; S B Desai; G S Sainani; S M Katrak
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-19       Impact factor: 3.825

7.  Vertical transmission in chikungunya infection.

Authors:  M P Senanayake; S M Senanayake; K K Vidanage; S Gunasena; S P Lamabadusuriya
Journal:  Ceylon Med J       Date:  2009-06

8.  Zika Virus Outbreak, Bahia, Brazil.

Authors:  Gubio S Campos; Antonio C Bandeira; Silvia I Sardi
Journal:  Emerg Infect Dis       Date:  2015-10       Impact factor: 6.883

9.  Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion.

Authors:  Patrick Gérardin; Georges Barau; Alain Michault; Marc Bintner; Hanitra Randrianaivo; Ghassan Choker; Yann Lenglet; Yasmina Touret; Anne Bouveret; Philippe Grivard; Karin Le Roux; Séverine Blanc; Isabelle Schuffenecker; Thérèse Couderc; Fernando Arenzana-Seisdedos; Marc Lecuit; Pierre-Yves Robillard
Journal:  PLoS Med       Date:  2008-03-18       Impact factor: 11.069

10.  The expanding spectrum of modes of transmission of Zika virus: a global concern.

Authors:  Alfonso J Rodriguez-Morales; Antonio Carlos Bandeira; Carlos Franco-Paredes
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-03-03       Impact factor: 3.944

View more
  22 in total

Review 1.  Chikungunya fever: a threat to global public health.

Authors:  Raíza Nara Cunha Moizéis; Thales Allyrio Araújo de Medeiros Fernandes; Paulo Marcos da Matta Guedes; Hannaly Wana Bezerra Pereira; Daniel Carlos Ferreira Lanza; Judson Welber Veríssimo de Azevedo; Josélio Maria de Araújo Galvão; José Veríssimo Fernandes
Journal:  Pathog Glob Health       Date:  2018-05-28       Impact factor: 2.894

2.  Brain MR Imaging of Patients with Perinatal Chikungunya Virus Infection.

Authors:  D G Corrêa; T A L Freddi; H Werner; F P P L Lopes; M E L Moreira; F C P de Almeida Di Maio Ferreira; J M de Andrade Lopes; F C Rueda-Lopes; L C H da Cruz
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-05       Impact factor: 3.825

Review 3.  Zika virus and the nonmicrocephalic fetus: why we should still worry.

Authors:  Christie L Walker; Marie-Térèse E Little; Justin A Roby; Blair Armistead; Michael Gale; Lakshmi Rajagopal; Branden R Nelson; Noah Ehinger; Brittney Mason; Unzila Nayeri; Christine L Curry; Kristina M Adams Waldorf
Journal:  Am J Obstet Gynecol       Date:  2018-08-29       Impact factor: 8.661

4.  Infectious Chikungunya Virus (CHIKV) with a Complete Capsid Deletion: a New Approach for a CHIKV Vaccine.

Authors:  Ya-Nan Zhang; Cheng-Lin Deng; Jia-Qi Li; Na Li; Qiu-Yan Zhang; Han-Qing Ye; Zhi-Ming Yuan; Bo Zhang
Journal:  J Virol       Date:  2019-07-17       Impact factor: 5.103

5.  High-Titer Self-Propagating Capsidless Chikungunya Virus Generated in Vero Cells as a Strategy for Alphavirus Vaccine Development.

Authors:  Ya-Nan Zhang; Zhe-Rui Zhang; Na Li; Xin-Ru Pei; Xiao-Dan Li; Cheng-Lin Deng; Han-Qing Ye; Bo Zhang
Journal:  J Virol       Date:  2022-02-02       Impact factor: 6.549

6.  Prolonged shedding of Chikungunya virus in semen and urine: A new perspective for diagnosis and implications for transmission.

Authors:  Antonio Carlos Bandeira; Gubio Soares Campos; Veronica França Diniz Rocha; Bruno Solano de Freitas Souza; Milena Botelho Pereira Soares; Alexsandro Araujo Oliveira; Yara Carvalho de Abreu; Gabriela Sant Ana Menezes; Silvia Ines Sardi
Journal:  IDCases       Date:  2016-11-04

Review 7.  The neurological complications of chikungunya virus: A systematic review.

Authors:  Ravi Mehta; Patrick Gerardin; Carlos Alexandre Antunes de Brito; Cristiane Nascimento Soares; Maria Lucia Brito Ferreira; Tom Solomon
Journal:  Rev Med Virol       Date:  2018-04-19       Impact factor: 6.989

8.  Functional and structural characterization of the chikungunya virus translational recoding signals.

Authors:  Joseph A Kendra; Vivek M Advani; Bin Chen; Joseph W Briggs; Jinyi Zhu; Hannah J Bress; Sushrut M Pathy; Jonathan D Dinman
Journal:  J Biol Chem       Date:  2018-09-21       Impact factor: 5.157

Review 9.  Small Molecule Inhibitors Targeting Chikungunya Virus.

Authors:  Nicole Haese; John Powers; Daniel N Streblow
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

Review 10.  Mother-to-child transmission of Chikungunya virus: A systematic review and meta-analysis.

Authors:  Despina Contopoulos-Ioannidis; Shoshana Newman-Lindsay; Camille Chow; A Desiree LaBeaud
Journal:  PLoS Negl Trop Dis       Date:  2018-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.